Category: General

CHC_general1

02/19/2019

FTC Flexes Enforcement Muscles, Joins FDA in Cracking Down on Alzheimer’s Claims

02/01/2019

Guest Commentary: What Might a Part B IPI Model Do to Drug Innovation, Patient Care?

News3.Jim Czaban

01/03/2019

Top 10 Compliance Tips for Healthcare Communications Companies

CHC_general1

02/20/2018

HHS’ Azar Lists Drug Pricing as One of Four Top HHS Priorities

CHC_FDA-Regulatory Images2

01/08/2018

NJ Gift Ban Linking Compliance with Physician Licensure Is Finalized

CHC_general1

07/31/2017

Inside the Opioid Crisis: The Intersection of Policy, Industry, and Health Outcomes

CHC_general1

10/25/2016

Coalition Commentary: How Information Flows … or Doesn’t

10/17/2016

Kamp: Pharma Needs to Step up to Stem Opioid Abuse

CHC_general2

09/01/2016

Study Shows ACA Increases Use of Rx Drugs, Decreases Out-of-pocket Spending